{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-009735","form_type":"8-K/A","ticker":"OPK","cik":"0000944809","company_name":"OPKO HEALTH, INC.","filed_at":"2024-03-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.376666+00:00","generated_at":"2026-06-04T06:53:29.156737+00:00","sec_items":["9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"low","headline":"OPKO files 8-K/A to update investor presentation after BioReference asset sale to LabCorp","bullets":["Asset Purchase Agreement with LabCorp for BioReference Health, LLC signed March 27, 2024.","This amendment replaces the January investor presentation with a March 27, 2024 version.","Exhibit 2.1 (Asset Purchase Agreement) filed with schedules omitted; no deal value disclosed.","No financial or operational details from the updated presentation available in this filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-009735","json":"https://secwatch.observer/filing/0001437749-24-009735.json","markdown":"https://secwatch.observer/filing/0001437749-24-009735.md","text":"https://secwatch.observer/filing/0001437749-24-009735.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/944809/000143774924009735/0001437749-24-009735-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/944809/000143774924009735/opk20240328_8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T06:53:29.156737+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}